Duchén K, Yu G, Björkstén B
Department of Paediatrics, Linköping University, Sweden.
Pediatr Res. 1998 Oct;44(4):478-84. doi: 10.1203/00006450-199810000-00003.
The levels of the long chain polyunsaturated n-6 and n-3 fatty acids (PUFA) were studied in colostrum and mature milk of 29 atopic and 29 nonatopic mothers and related to sensitization in their babies during the first 12 mo of life. The levels of alpha-linolenic acid (LNA) were lower (0.96 versus 1.23 weight percentage, p < 0.01) and the levels of dihomo-gamma-linoleic acid were higher (0.36 versus 0.31 weight percentage, p < 0.05) in mature milk from mothers of atopic babies (n = 24) compared with mothers of nonatopic babies (n = 34). The total n-3 levels and the ratio of n-6 PUFA/n-3 PUFA were similar in colostrum of all mothers and then decreased significantly in mature milk (p < 0.001), particularly in milk given to atopic babies. The levels of the n-6 fatty acids arachidonic acid, C22:4, and C22:5 n-6 correlated in milk samples from nonatopic mothers (r = 0.61-0.97, p < 0.05 to p < 0.001) but were largely absent in colostrum and mature milk from atopic mothers. In contrast, LNA and eicosapentaenoic levels correlated in colostrum from the atopic mothers (r = 0.61-0.88) regardless of atopic sensitization in the infants, whereas LNA correlated to C20:4 n-3 in colostrum from nonatopic mothers of nonatopic infants. Furthermore, the levels of the n-3 fatty acid C20:4 n-3 correlated significantly to all n-6 fatty acids, except linoleic acid (r = 0.64-0.79, all p < 0.01) in mature milk from nonatopic mothers of nonsensitized children. Low levels of LNA and total n-3 long chain polyunsaturated fatty acids, in mature milk from the mothers, appear to be associated with atopic sensitization early in life, as well as disturbed relationships between the n-3 fatty acid 20:4 and the n-6 fatty acids particularly in mature milk. On the other hand, disturbed relationships within the individual fatty acids in the n-6 series in human milk reflected the atopic status in the mothers. The variations in the lipid composition of human milk could in part explain some of the controversies regarding the protective effects of breast-feeding against allergy.
对29位患特应性疾病的母亲和29位非特应性疾病的母亲的初乳和成熟乳中的长链多不饱和n-6和n-3脂肪酸(PUFA)水平进行了研究,并将其与她们宝宝在出生后12个月内的致敏情况相关联。与非特应性宝宝的母亲(n = 34)相比,特应性宝宝的母亲(n = 24)的成熟乳中α-亚麻酸(LNA)水平较低(0.96%对1.23%,p < 0.01),而二高-γ-亚麻酸水平较高(0.36%对0.31%,p < 0.05)。所有母亲初乳中的总n-3水平以及n-6 PUFA/n-3 PUFA比值相似,而在成熟乳中则显著下降(p < 0.001),特别是在给特应性宝宝的乳汁中。非特应性母亲的乳汁样本中n-6脂肪酸花生四烯酸、C22:4和C22:5 n-6的水平具有相关性(r = 0.61 - 0.97,p < 0.05至p < 0.001),但在特应性母亲的初乳和成熟乳中基本不存在。相反,特应性母亲初乳中的LNA和二十碳五烯酸水平具有相关性(r = 0.61 - 0.88),与婴儿是否患特应性疾病无关,而非特应性婴儿的非特应性母亲的初乳中LNA与C20:4 n-3具有相关性。此外,在未致敏儿童的非特应性母亲的成熟乳中,n-3脂肪酸C20:4 n-3水平与除亚油酸外的所有n-6脂肪酸均显著相关(r = 0.64 - 0.79,所有p < 0.01)。母亲成熟乳中LNA和总n-3长链多不饱和脂肪酸水平较低,似乎与生命早期的特应性致敏有关,以及n-3脂肪酸20:4与n-6脂肪酸之间的关系紊乱,特别是在成熟乳中。另一方面,人乳中n-6系列中各脂肪酸之间的关系紊乱反映了母亲的特应性状态。人乳脂质组成的变化可能部分解释了关于母乳喂养对过敏的保护作用的一些争议。